Adagio Medical Holdings (ADGM) Free Cash Flow (2023 - 2026)

Adagio Medical Holdings (ADGM) has 4 years of Free Cash Flow data on file, last reported at -$4.1 million in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow rose 45.3% year-over-year to -$4.1 million; the trailing twelve-month figure through Mar 2026 stood at -$7.8 million (up 63.01% YoY), and the FY2025 full-year result was -$19.4 million, down 31.45% from the prior year.
• Free Cash Flow retreated to -$4.1 million in Q1 2026, from -$3.6 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$3.6 million in Q4 2025 to a low of -$7.5 million in Q1 2025.
• A 4-year average of -$6.1 million and a median of -$6.8 million in 2023 frame the typical range for Free Cash Flow.
• Across the five-year window, Free Cash Flow fell 9.35% in 2025 and surged 45.3% in 2026, its largest moves.
• Tracing ADGM's Free Cash Flow over 4 years: stood at -$6.8 million in 2023, then retreated by 2.23% to -$6.9 million in 2024, then surged by 47.77% to -$3.6 million in 2025, then decreased by 13.94% to -$4.1 million in 2026.
• Business Quant data shows ADGM's Free Cash Flow at -$4.1 million in Q1 2026, -$3.6 million in Q4 2025, and -$7.5 million in Q1 2025.